Quarterly report [Sections 13 or 15(d)]

STATEMENTS OF CASH FLOWS

v3.25.3
STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flow from Operating Activities:    
Net Loss $ (6,388,262) $ (11,321,312)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Share-Based Compensation 952,607 2,256,712
Share-Based Payments to Vendors 241,319 640,500
(Increase)/Decrease in:    
Other Receivable 10,919 31,786
Prepaid Expenses (58,078) (17,046)
Accounts Payable and Accrued Expenses (361,547) 276,327
Net Cash Used in Operating Activities (5,603,042) (8,133,033)
Cash Flow from Financing Activities:    
Reverse stock split fractional share adjustment (1,040)  
Proceeds from 2025 Warrant Exercise, net of issuance costs 2,480,553  
Proceeds from issuance of common stock in connection with equity line of credit purchase agreement, net of issuance costs 2,334,945  
Proceeds from 2025 March Registered Direct Offering, net of issuance costs 889,420  
Proceeds from 2025 January Registered Direct Offering, net of issuance costs 2,099,253  
Proceeds from At-the-Market Offering, net of issuance costs   6,211,210
Proceeds from 2024 Warrant Exercise   210,199
Net Cash Provided by Financing Activities 7,803,131 6,421,409
Net Increase/(Decrease) in Cash 2,200,089 (1,711,624)
Cash at Beginning of Period 3,706,713 7,474,188
Cash at End of Period 5,906,802 $ 5,762,564
SUPPLEMENTAL DISCLOSURE OF NON-CASH OPERATING ACTIVITIES    
Share-Based Compensation To settle accrued compensation (Note 5) 413,120  
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES    
2025 Equity Line of Credit Purchase Agreement costs (Commitment shares) (Note 4) 360,000  
2025 Warrant Inducement Financing cost (Note 4) $ 4,636,869